Therapeutic potential of fetal mesenchymal stem cells.

Fetal vs adult mesenchymal stem cells achieve greater gene expression, but less osteoinduction. World J Stem Cells (2015) 0.77

Profilin 1 is a potential biomarker for bladder cancer aggressiveness. Mol Cell Proteomics (2011) 1.14

Therapeutic potential of a distinct population of human amniotic fluid mesenchymal stem cells and their secreted molecules in mice with acute hepatic failure. Gut (2011) 1.08

Sox2 suppression by miR-21 governs human mesenchymal stem cell properties. Stem Cells Transl Med (2013) 0.97

Stem cells: insights into the secretome. Biochim Biophys Acta (2013) 0.95

OCT4 spliced variant OCT4B1 is expressed in human colorectal cancer. Mol Carcinog (2011) 0.93

Analysis of secreted proteins for the study of bladder cancer cell aggressiveness. J Proteome Res (2010) 0.89

Human amniotic fluid stem cells as an attractive tool for clinical applications. Curr Stem Cell Res Ther (2013) 0.88

A novel function for the haemopoietic supportive murine bone marrow MS-5 mesenchymal stromal cell line in promoting human vasculogenesis and angiogenesis. Br J Haematol (2012) 0.86

Human amniotic fluid-derived mesenchymal stem cells as therapeutic vehicles: a novel approach for the treatment of bladder cancer. Stem Cells Dev (2011) 0.86

Chromosomal and proteome analysis of a new T24-based cell line model for aggressive bladder cancer. Proteomics (2009) 0.83

Stem cells as potential targeted therapy for inflammatory bowel disease. Inflamm Bowel Dis (2014) 0.81

Antiviral Stratagems Against HIV-1 Using RNA Interference (RNAi) Technology. Evol Bioinform Online (2013) 0.81

The hematopoietic chemokine CXCL12 promotes integration of human endothelial colony forming cell-derived cells into immature vessel networks. Stem Cells Dev (2014) 0.80

Fetal mesenchymal stem cells in cancer therapy. Curr Stem Cell Res Ther (2013) 0.77